EZH2 and prostate cancer: EZH2 also negatively regulates the transcription of the metastasis suppressor gene RKIP in breast and prostate cancer by regulating H3K27 and H3K9-me3 modifications, leading to negative association of EZH2 expression with relapse-free survival in breast cancer [131].